Furthermore, long-term studies revealed that serum XT-I activity of SSc patients remains increased [25], corresponding to elevated PG metabolism and increased GAG content found in skin biopsies or cultured SSc fibroblasts [40,41]. This evidence concerns the gene XYLT1 and systemic sclerosis.